MAIA

Maia Biotechnology INC

+$14.3M

Net Activity

Institutions Holding

32

Popularity Rank

#7094

Avg Weight

0.13%

Total Value

$18.4M

Ownership Trend

32 institutions currently hold MAIA, with 17 net buyers and 7 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

7

Net Buying Institutions

17

Key Holders

View all 32 holding institutions

Quarterly Activity

Recent Activity

+$15.0M

Total Buy Value

$205.8K

Total Sell Value

New buy10
Trim2
Add7
Sold out5

17

Net Buyers

7

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding MAIA BIOTECHNOLOGY INC (MAIA)?
Major stakeholders currently include Solas Capital Management, LLC ($6.0M), Alyeska Investment Group, L.P. ($3.5M), Vanguard Capital Management LLC ($2.9M). Based on the latest 13F filings, there are a total of 32 tracked investment funds and institutions maintaining positions in MAIA.
What is the overall institutional sentiment toward MAIA recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $14.3M, driven by 17 managers accumulating shares while 7 reduced their exposure.
Which institutions have been selling or reducing their MAIA positions?
In the latest period, 2 funds trimmed their holdings, and 5 managers completely exited their positions. The aggregate reported sell value was $205.8K.
Are there any notable investors adding MAIA to their portfolios?
Yes, buying activity remains notable. 10 institutions opened new positions in {ticker}, and 7 existing holders added to their shares. The total reported buy value for the quarter amounted to $15.0M.

Related Stocks